Koyfin Home > Directory > Health Care > Acorda Therapeutics > Price / Book

Acorda Therapeutics Price / Book Chart (ACOR)

Acorda Therapeutics annual/quarterly Price / Book from 2010 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Acorda Therapeutics Price / Book for the quarter ending September 09, 2020 was 0.09 a 5.61% increase of 0.00 year over year
  • Acorda Therapeutics Price / Book for the last 12 months ending September 09, 2020 was 0.09 a 5.61% increase of 0.00 year over year
  • Acorda Therapeutics Annual Price / Book for 2020 was 0.09 a -7.46% decrease of -0.01 from 2019
  • Acorda Therapeutics Annual Price / Book for 2020 was 0.10 a 5.24% increase of 0.00 from 2019
  • Acorda Therapeutics Annual Price / Book for 2020 was 0.09 a 7.31% increase of 0.01 from 2019
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $1,138m a 2.19% increase of 25m year over year
View Chart On Koyfin

Quarterly ACOR Price / Book Data

09/20200.09
09/20200.10
09/20200.09
09/20200.08
09/20200.07
09/20200.07
09/20200.08
09/20200.08
09/20200.08
09/20200.08

Annual ACOR Price / Book Data

20200.09
20200.10
20200.09
20200.08
20200.07
20200.07
20200.08
20200.08
20200.08
20200.08